Tuberculosis: Commentary on a Reemergent Killer

Tuberculosis remains the leading cause of death in the world from a single infectious disease, although there is little knowledge of the mechanisms of its pathogenesis and protection from it. After a century of decline in the United States, tuberculosis is increasing, and strains resistant to multiple antibiotics have emerged. This excess of cases is attributable to changes in the social structure in cities, the human immunodeficiency virus epidemic, and a failure in certain major cities to improve public treatment programs. The economic costs of not adequately addressing the problem of tuberculosis in this country are estimated from an epidemiological model.

[1]  J. Thomas,et al.  A method for estimating the prevalence of tuberculosis infection. , 1975, American journal of epidemiology.

[2]  P. D. Hart,et al.  The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines , 1967 .

[3]  W. Jacobs,et al.  Introduction of foreign DNA into mycobacteria using a shuttle phasmid , 1987, Nature.

[4]  I. Orme Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines , 1988, Infection and immunity.

[5]  R. Henderson,et al.  Expanded programme on immunization. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[6]  M. Sogin,et al.  Direct detection of Mycobacterium tuberculosis in clinical specimens by DNA amplification , 1990, Journal of clinical microbiology.

[7]  E. C. Mooney,et al.  The white plague. , 1979, American heritage.

[8]  V. Kindler,et al.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection , 1989, Cell.

[9]  J. Sbarbaro The patient-physician relationship: compliance revisited. , 1990, Annals of allergy.

[10]  W. Fox Compliance of patients and physicians: experience and lessons from tuberculosis-II. , 1983, British medical journal.

[11]  P. G. Smith,et al.  Epidemiologic Problems and Prospects , 1989 .

[12]  R. Locksley,et al.  Tumour necrosis factor α restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice , 1992, Nature.

[13]  J. Phair,et al.  Airborne Contagion and Air Hygiene , 1955 .

[14]  S. Petroff,et al.  BIOLOGICAL STUDIES OF THE TUBERCLE BACILLUS : III. DISSOCIATION AND PATHOGENICITY OF THE R AND S VARIANTS OF THE HUMAN TUBERCLE BACILLUS (H37) , 1934 .

[15]  D. Snider,et al.  Tuberculosis in patients with human immunodeficiency virus infection. , 1991, The New England journal of medicine.

[16]  W. Jacobs,et al.  Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guérin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Bernardo,et al.  Tuberculosis screening in Boston's homeless shelters. , 1986, Public health reports.

[18]  G. Comstock Identification of an effective vaccine against tuberculosis. , 1988, The American review of respiratory disease.

[19]  G. Rook,et al.  The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. , 1987, Immunology.

[20]  M. Caldwell The last crusade : the war on consumption, 1862-1954 , 1989 .

[21]  P. Brennan,et al.  Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. , 1990, Journal of immunology.

[22]  W. Jacobs,et al.  Lysogeny and transformation in mycobacteria: stable expression of foreign genes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Chaisson,et al.  Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. , 1991, The New England journal of medicine.

[24]  D. Soll,et al.  Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis , 1991, Journal of clinical microbiology.

[25]  P. Shankar,et al.  Identification of Mycobacterium tuberculosis by polymerase chain reaction , 1990, The Lancet.

[26]  ten Dam Hg,et al.  Does BCG vaccination protect the newborn and young infants , 1980 .

[27]  W. Willett,et al.  A case-control study of BCG and childhood tuberculosis in Cali, Colombia. , 1985, International journal of epidemiology.

[28]  P. Barnes,et al.  Mycobacterial disease in patients with human immunodeficiency virus infection. , 1989, Archives of internal medicine.

[29]  W. Boom,et al.  Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes , 1991, Infection and immunity.

[30]  National action plan to combat multidrug-resistant tuberculosis. , 1992, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[31]  C. Murray,et al.  Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries , 1991, The Lancet.

[32]  K. Hyams,et al.  Tuberculin skin testing in US Navy and Marine Corps personnel and recruits, 1980-86. , 1990, American journal of public health.

[33]  Selman A. Waksman,et al.  The Conquest of Tuberculosis , 2021 .

[34]  S. Kaufmann,et al.  CD8+ T lymphocytes in intracellular microbial infections. , 1988, Immunology today.

[35]  B. Bloom,et al.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.

[36]  J. Garthwaite Glutamate, nitric oxide and cell-cell signalling in the nervous system , 1991, Trends in Neurosciences.

[37]  P. Barnes,et al.  Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. , 1989, Journal of immunology.

[38]  D. Risser,et al.  An outbreak of tuberculosis in a shelter for homeless men. A description of its evolution and control. , 1991, The American review of respiratory disease.

[39]  S. Vermund,et al.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.

[40]  T. To,et al.  The significance of the tuberculin skin test in elderly persons. , 1987, Annals of internal medicine.

[41]  E. Nardell,et al.  Exogenous reinfection with tuberculosis in a shelter for the homeless. , 1986, The New England journal of medicine.

[42]  D. Snider,et al.  Epidemiology of tuberculosis in the United States. , 1989, Epidemiologic reviews.

[43]  A. Vennema The status of tuberculosis control in New York City. , 1982, Public health reports.

[44]  R. Young,et al.  Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines , 1991, Nature.

[45]  R. Haley,et al.  Tuberculosis epidemic among hospital personnel. , 1989 .

[46]  R. O'brien,et al.  USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. , 1990, Annals of internal medicine.

[47]  S. Kaufmann,et al.  Mycobacterial protein antigens: a compilation , 1992, Molecular microbiology.

[48]  Ronald Arbuthnott Knox,et al.  On English translation , 1973 .

[49]  L G Escobedo,et al.  Behavioral Risk Factor Surveillance, 1988. , 1990, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[50]  D. Mitchison THE TUBERCLE BACILLUS , 1959 .

[51]  J. E. Perkins,et al.  Effect of Ultra-violet Irradiation of Classrooms on Spread of Measles in Large Rural Central Schools Preliminary Report. , 1947, American journal of public health and the nation's health.

[52]  G. Rook Role of activated macrophages in the immunopathology of tuberculosis. , 1988, British medical bulletin.

[53]  H. G. ten Dam,et al.  The effectiveness of BCG vaccination of the newborn against childhood tuberculosis in Bangkok. , 1986, Bulletin of the World Health Organization.

[54]  P. Fine,et al.  BCG vaccination against tuberculosis and leprosy. , 1988, British medical bulletin.

[55]  M. Denis Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. , 1991, Cellular immunology.

[56]  G. Schoolnik,et al.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. , 1992, The New England journal of medicine.

[57]  M. Horwitz,et al.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.

[58]  A. Calmette La vaccination preventive contre la tuberculose par le "BCG" , 1927 .

[59]  S. Jonjić,et al.  Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.

[60]  P. Barnes,et al.  Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. , 1990, The American journal of medicine.

[61]  M. Horwitz,et al.  Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. , 1991, Journal of immunology.

[62]  H. G. ten Dam,et al.  The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. , 1986, Tubercle.

[63]  M. J. Kuhar,et al.  The dopamine hypothesis of the reinforcing properties of cocaine , 1991, Trends in Neurosciences.

[64]  G W Comstock,et al.  The prognosis of a positive tuberculin reaction in childhood and adolescence. , 1974, American journal of epidemiology.

[65]  W. Jacobs,et al.  New use of BCG for recombinant vaccines , 1991, Nature.

[66]  O. Horwitz,et al.  Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area. , 1969, Bulletin of the World Health Organization.

[67]  G. Rosen National Tuberculosis Association 1904-1954. A Study of the Voluntary Health Movement in the United States , 1958 .

[68]  R. Luzzati,et al.  NOSOCOMIAL EPIDEMIC OF ACTIVE TUBERCULOSIS AMONG HIV-INFECTED PATIENTS , 1989, The Lancet.

[69]  P. Brennan,et al.  Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information. , 1991, Research in microbiology.

[70]  W. Gross,et al.  Base Composition of Deoxyribonucleic Acid Isolated from Mycobacteria , 1968, Journal of bacteriology.

[71]  I. Orme,et al.  Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. , 1984, Cellular immunology.

[72]  P. Andersen,et al.  T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis , 1991, Infection and immunity.

[73]  A. Dannenberg Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. , 1991, Immunology today.